fda warning letter bpc-157 peptide compounding unapproved new drug The U.S. Food and Drug Administration is moving toward allowing pharmacies ⁠to produce more than a dozen injectable peptides that were banned fda warning letter compounding pharmacy

Research confirmed that AOD-9604 elicits its fat-reducing effects without inducing insulin resistance

Introducing a poorly synthesized or contaminated version of this peptide is not just bad scienceit's a complete waste of time and resources

Vanessa Mack (Dean) and her team provide ongoing guidance and monitor patient progress to help determine whether adjustments to a B12 injection schedule may be needed

This deep dive covers the clinical evidence, mechanisms, who benefits most, and how to approach a PMOS fertility metabolic plan.

Lyophilized compounds, solution preparations, encapsulated products, and aerosol research products should be reviewed using the applicable product label, COA, and internal laboratory handling standards

Effect of deproteinization and reagent buffer on the enzymatic assay of L-carnitine in serum